{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:46:22Z","timestamp":1787010382839,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Deceased donor and recipient predictors of posttransplant steatosis\/steatohepatitis and fibrosis are not well known. Our aim was to evaluate the prevalence and assess donor and recipient predictors of steatosis, steatohepatitis, and fibrosis in liver transplantation recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Using the immune tolerance network A-WISH multicenter study (NCT00135694), donor and recipient demographic and clinical features were collected. Liver biopsies were taken from the donor liver at transplant, and from recipients per protocol and for-cause (ie, abnormal transaminases and to rule out rejection) and were interpreted by a central pathologist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>One hundred eighty-three paired donor\/recipients liver biopsies at the time of transplant and posttransplant follow-up (median time 582 d; average time to last biopsies was 704 d [SD\u2009\u00b1\u2009402 d]) were analyzed. Donor steatosis did not influence recipient steatosis or fibrosis. Ten of 183 recipients had steatohepatitis on the last biopsy. Recipient body mass index at the time of liver biopsy was the most influential factor associated with posttransplant steatosis. Both donor and recipient metabolic syndrome features were not associated with graft steatosis. Untreated hepatitis C viral (HCV) infection was the most influential factor associated with the development of allograft fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>In a large experience evaluating paired donor and recipient characteristics, recipient body mass index at the time of liver biopsy was most significantly associated with posttransplant steatosis. Untreated HCV etiology influenced graft fibrosis. Thus relative to untreated HCV, hepatic fibrosis in those with steatosis\/steatohepatitis is less common though long-term follow-up is needed to determine the course of posttransplant fibrosis. Emphasis on recipient weight control is essential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000003681","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:46:55Z","timestamp":1614214015000},"page":"106-116","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis\/Fibrosis Following Liver Transplantation"],"prefix":"10.1097","volume":"106","author":[{"given":"Oren","family":"Shaked","sequence":"first","affiliation":[{"name":"Department of Surgery, University of California San Francisco, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Demetris","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Levitsky","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Comprehensive Transplant Center, Northwestern Memorial Hospital, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California San Francisco, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Li","family":"Loza","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Punch","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Michigan, Ann Arbor, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Reyes","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Klintmalm","sequence":"additional","affiliation":[{"name":"Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Jackson","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Colorado Denver, Aurora, CO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"DesMarais","sequence":"additional","affiliation":[{"name":"Immune Tolerance Network, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sayre","sequence":"additional","affiliation":[{"name":"Immune Tolerance Network, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Shaked","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"R1-20250604","first-page":"86","article-title":"Recurrent disease after liver transplantation.","volume":"9","author":"Davern","year":"1998","journal-title":"Semin Gastrointest Dis"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/SLA.0b013e31826b4b7e","article-title":"Liver transplantation for nonalcoholic steatohepatitis: the new epidemic.","volume":"256","author":"Agopian","year":"2012","journal-title":"Ann Surg"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/00007890-199611150-00011","article-title":"Use of fatty donor liver is associated with diminished early patient and graft survival.","volume":"62","author":"Marsman","year":"1996","journal-title":"Transplantation"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1499-3872(17)60064-X","article-title":"Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation.","volume":"16","author":"Andert","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ajg.2009.717","article-title":"Non-alcoholic fatty liver disease in liver transplant recipients: another story of \u201cseed and soil\u201d.","volume":"105","author":"Dumortier","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/TP.0b013e31820b6b84","article-title":"NAFLD recurrence in liver transplant recipients.","volume":"91","author":"Dureja","year":"2011","journal-title":"Transplantation"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/ctr.12343","article-title":"Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.","volume":"28","author":"Kim","year":"2014","journal-title":"Clin Transplant"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/ajt.15205","article-title":"Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.","volume":"19","author":"Shaked","year":"2019","journal-title":"Am J Transplant"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis.","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cgh.2017.11.045","article-title":"Alcoholic liver disease replaces hepatitis c virus infection as the leading indication for liver transplantation in the United States.","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin Gasterentol Hepatol"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/MEG.0000000000001105","article-title":"De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients.","volume":"30","author":"Gitto","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/lt.24223","article-title":"De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.","volume":"21","author":"Idowu","year":"2015","journal-title":"Liver Transpl"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/lt.21927","article-title":"Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.","volume":"15","author":"Bhagat","year":"2009","journal-title":"Liver Transpl"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/lt.24393","article-title":"Prevalence and risk factors of steatosis after liver transplantation and patient outcomes.","volume":"22","author":"Hejlova","year":"2016","journal-title":"Liver Transpl"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/lt.20932","article-title":"De novo nonalcoholic fatty liver disease after liver transplantation.","volume":"13","author":"Seo","year":"2007","journal-title":"Liver Transpl"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.23936","article-title":"Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.","volume":"20","author":"Vallin","year":"2014","journal-title":"Liver Transpl"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease.","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.transproceed.2005.11.088","article-title":"Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?","volume":"38","author":"Ha\u0142o\u0144","year":"2006","journal-title":"Transplant Proc"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/TP.0b013e318223d817","article-title":"Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model.","volume":"92","author":"Jamieson","year":"2011","journal-title":"Transplantation"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/lt.25338","article-title":"Predictors of de novo nonalcoholic fatty liver disease after liver transplantation and associated fibrosis.","volume":"25","author":"Galvin","year":"2019","journal-title":"Liver Transpl"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","article-title":"Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.","volume":"16","author":"Yalamanchili","year":"2010","journal-title":"Liver Transpl"},{"issue":"Suppl 3","key":"R25-20250604","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/lt.22386","article-title":"Metabolic syndrome: is immunosuppression to blame?","volume":"17","author":"Watt","year":"2011","journal-title":"Liver Transpl"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:24:34Z","timestamp":1749050674000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003681","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,13]]}}}